ClinicalTrials.gov
ClinicalTrials.gov Menu

Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00912067
Recruitment Status : Unknown
Verified June 2009 by Sheba Medical Center.
Recruitment status was:  Enrolling by invitation
First Posted : June 3, 2009
Last Update Posted : June 3, 2009
Sponsor:
Information provided by:
Sheba Medical Center

Brief Summary:
The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

Condition or disease
Graft Versus Host Disease

Study Type : Observational
Estimated Enrollment : 120 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults
Study Start Date : July 2009

Resource links provided by the National Library of Medicine


Group/Cohort
hematopoietic stem cell transplantation




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
adults after hematopoietic stem cell transplantation done at sheba medical center Israel during the last 3 years
Criteria

Inclusion Criteria:

  • after hematopoietic stem cell transplantation done at sheba medical center Israel
  • 3 month have past from transplantation but no more then 3 years

Exclusion Criteria:

  • transplantation done in the last 3 month or more than 3 years have past since

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00912067


Locations
Israel
Sheba Medical Center
Tel Hashomer, Israel, 52621
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: irina barequet, MD Sheba Medical Center

Publications:
Responsible Party: Irina Barequet MD/PI, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00912067     History of Changes
Other Study ID Numbers: SHEBA-09-7085-IB-CTIL
First Posted: June 3, 2009    Key Record Dates
Last Update Posted: June 3, 2009
Last Verified: June 2009

Additional relevant MeSH terms:
Graft vs Host Disease
Immune System Diseases